Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
JOINN Laboratories (China) Co., Ltd. Class H ( (HK:6127) ) has provided an announcement.
JOINN Laboratories (China) Co., Ltd. has established a Remuneration and Evaluation Committee to enhance its governance structure by managing remuneration and evaluation for its directors and senior management. This committee is tasked with formulating assessment standards, reviewing remuneration policies, and ensuring transparent procedures for developing remuneration strategies, which could strengthen the company’s operational efficiency and align management incentives with corporate goals.
The most recent analyst rating on (HK:6127) stock is a Hold with a HK$16.30 price target. To see the full list of analyst forecasts on JOINN Laboratories (China) Co., Ltd. Class H stock, see the HK:6127 Stock Forecast page.
More about JOINN Laboratories (China) Co., Ltd. Class H
JOINN Laboratories (China) Co., Ltd. operates within the pharmaceutical and biotechnology industry, focusing on providing laboratory services and solutions. The company is primarily engaged in the evaluation and testing of pharmaceutical products, contributing to the development and safety assessment of new drugs.
Average Trading Volume: 6,769,040
Technical Sentiment Signal: Buy
Current Market Cap: HK$26.27B
Learn more about 6127 stock on TipRanks’ Stock Analysis page.